TIDMACRL

RNS Number : 2982D

Accrol Group Holdings PLC

18 October 2022

18 October 2022

Accrol Group Holdings plc

("Accrol", the "Company" or the "Group")

AIM: ACRL

Result of 2022 Annual General Meeting

Accrol, the leading independent tissue converter in the UK, announces that all of the resolutions set out in the Notice of AGM were passed by the requisite majority at the Company's AGM, held earlier today.

Details of the proxy votes received by the Company are as follows:

 
 Resolution                                For                  Against              Withheld 
                                  No. of votes        %   No. of votes       %   No. of votes 
                                 -------------  -------  -------------  ------  ------------- 
 1. To receive the Annual 
  Report and Accounts              189,816,491    99.95        103,474    0.05         10,759 
                                 -------------  -------  -------------  ------  ------------- 
 2. To appoint BDO as Auditor      189,621,942    99.84        298,023    0.16         10,759 
                                 -------------  -------  -------------  ------  ------------- 
 3. To approve the Directors' 
  Remuneration Report              179,946,678    94.75      9,973,287    5.25         10,759 
                                 -------------  -------  -------------  ------  ------------- 
 4. To re-elect Simon Allport 
  as a Director                    188,359,619    99.28      1,360,346    0.72        210,759 
                                 -------------  -------  -------------  ------  ------------- 
 5. To authorise the Directors 
  to allot relevant securities     189,586,383    99.82        333,582    0.18         10,759 
                                 -------------  -------  -------------  ------  ------------- 
 6. To authorise the Directors 
  to allot equity securities 
  for cash without making 
  a pre-emptive offer to 
  shareholders*                    189,585,650    99.82        334,315    0.18         10,759 
                                 -------------  -------  -------------  ------  -------------

*Special resolution

Notes:

 
 1.   Proxy appointments which gave discretion to the Chairman 
       of the AGM have been included in 
       "For" total for the appropriate resolution. 
 2.   Votes "For" and "Against" any resolution are expressed as 
       a percentage of votes validly cast for that resolution. 
 3.   A "Vote withheld" is not a vote in law and is not counted 
       in the calculation of the percentage of shares voted "For" 
       or "Against". 
 4.   The number of shares in issue on 18 October 2022 was 318,878,097 
       with no shares in treasury. 
 5.   The full text of the resolutions passed at the AGM is available 
       in the Notice of AGM on the Company's website: 
       https://www.accrol.co.uk/app/uploads/2022/09/22-09-23-Accrol-Notice-of-AGM-Web-1.pdf. 
 
 
For further information, please contact: 
 
Accrol Group Holdings plc 
Dan Wright, Executive Chairman            Via Belvedere Communications 
Gareth Jenkins, Chief Executive Officer 
Richard Newman, Chief Financial Officer 
 
Zeus (Nominated Adviser & Broker) 
Dan Bate / Jordan Warburton                  Tel: +44 (0) 161 831 1512 
Dominic King                                 Tel: +44 (0) 203 829 5000 
 
Liberum Capital Limited (Joint Broker)       Tel: +44 (0) 20 3100 2222 
Clayton Bush / Edward Thomas 
 
Belvedere Communications Limited 
Cat Valentine                                Tel: +44 (0) 7715 769 078 
Keeley Clarke                                Tel: +44 (0) 7967 816 525 
                                              accrolpr@belvederepr.com

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the GBP2.1bn UK retail tissue market.

For more information, please visit www.accrol.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGLVLFFLBLLFBE

(END) Dow Jones Newswires

October 18, 2022 08:27 ET (12:27 GMT)

Accrol (LSE:ACRL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Accrol Charts.
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Accrol Charts.